AI-generated summary
The authors randomized 30 people with facial melasma so that one half of the face received topical 20% azelaic acid alone, and the other half received azelaic acid plus 755-nm picosecond laser. Both sides improved significantly, with no clinical difference between them apart from subtle differences seen on reflectance confocal microscopy. No serious adverse effects were reported.
- Participants
- 30
- Who or what was studied
- Adults with facial melasma treated at a single center in China
- Wavelengths
- 755 nm
- Limits stated in the abstract
- Single-center study with a small sample, and the abstract reports no clear difference between the treatment arms apart from subtle confocal microscopy findings.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.